Skip to main
PAYS
PAYS logo

PaySign Inc (PAYS) Stock Forecast & Price Target

PaySign Inc (PAYS) Analyst Ratings

Based on 4 analyst ratings
Strong Buy
Strong Buy 75%
Buy 25%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

PaySign Inc. is projected to achieve a 26% year-over-year increase in total revenue for 2025, reaching $73.4 million, supported by significant growth across its diverse service offerings. The company is also expected to experience a remarkable 72% year-over-year growth in adjusted EBITDA, forecasted at $16.6 million, with margins anticipated to expand by 610 basis points to 22.6%. Additionally, the strong performance in the Pharma segment is expected to contribute to adjusted EBITDA margins that may rise between 570 and 650 basis points, further solidifying the financial outlook for the company.

Bears say

PaySign Inc. experienced a significant decline in revenue within the Plasma Donor Compensation segment, posting a 9% year-over-year decrease to $9.4 million, which fell short of forecasts by $0.5 million. This downturn can be attributed to an oversupply of plasma in the U.S., exacerbated by new extraction techniques that enable higher plasma yield per donation, leading collection centers to reduce compensation for donors. Furthermore, the company faced a more extensive financial setback in 2020, with total revenue plunging 30% year-over-year to $24 million and adjusted EBITDA deteriorating to a loss of $2.8 million, down from a positive $10.1 million in 2019.

PaySign Inc (PAYS) has been analyzed by 4 analysts, with a consensus rating of Strong Buy. 75% of analysts recommend a Strong Buy, 25% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of PaySign Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About PaySign Inc (PAYS) Forecast

Analysts have given PaySign Inc (PAYS) a Strong Buy based on their latest research and market trends.

According to 4 analysts, PaySign Inc (PAYS) has a Strong Buy consensus rating as of Nov 27, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $8.06, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $8.06, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

PaySign Inc (PAYS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.